Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
November 19 2020 - 7:00AM
Business Wire
Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that
management will participate in two upcoming investor
conferences:
- Piper Sandler 32nd Annual Virtual Healthcare Conference
on December 1, 2020 where management will participate in 1x1
meetings. A fireside chat held with Seres management will be made
available on the News and Events section of the Company’s website
on November 23, 2020.
- 3rd Annual Evercore ISI HealthCONx Virtual Conference on
December 2, 2020. Management will participate in 1x1 meetings.
About Seres Therapeutics
Seres Therapeutics, Inc., (Nasdaq: MCRB) is a leading microbiome
therapeutics platform company developing a novel class of
multifunctional bacterial consortia that are designed to
functionally interact with host cells and tissues to treat disease.
Seres’ SER-109 program achieved the first-ever positive pivotal
clinical results for a targeted microbiome drug candidate and has
obtained Breakthrough Therapy and Orphan Drug designations from the
FDA. The SER-109 program is being advanced for the treatment of
recurrent C. difficile infection and has potential to become a
first-in-class FDA-approved microbiome therapeutic. Seres’ SER-287
program has obtained Fast Track and Orphan Drug designations from
the FDA and is being evaluated in a Phase 2b study in patients with
active mild-to-moderate ulcerative colitis. Seres is evaluating
SER-401 in a Phase 1b study in patients with metastatic melanoma,
SER-301 in a Phase 1b study in patients with ulcerative colitis and
SER-155 to prevent mortality due to gastrointestinal infections,
bacteremia and graft versus host disease. For more information,
please visit www.serestherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201119005223/en/
PR Contact Lisa Raffensperger
lisa@tenbridgecommunications.com
IR Contact Carlo Tanzi, Ph.D.
ctanzi@serestherapeutics.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2023 to Apr 2024
